Universal or targeted cardiovascular screening? Modelling study using a sector-specific distributional cost effectiveness analysis

作者: Brendan Collins , Chris Kypridemos , Richard Cookson , Paula Parvulescu , Philip McHale

DOI: 10.1016/J.YPMED.2019.105879

关键词:

摘要: Distributional cost effectiveness analysis is a new method that can help to redesign prevention programmes by explicitly modelling the distribution of health opportunity costs as well benefits. Previously we modelled cardiovascular disease (CVD) screening audit data from Liverpool, UK see if city could its programme enhance and equity. Building on this previous analysis, examined looked at options co-designed with stakeholders. We simulated four plausible scenarios: a) no CVD screening, b) ‘current’ basic universal currently implemented, c) enhanced ‘increased’ population-wide delivery, d) ‘universal plus targeted’ top-up delivery most deprived fifth. also compared assumptions around whether displaced spend would come might benefit poor more how much these generate. The main outcomes were net change in slope index inequality (SII) QALYs per 100,000 person years. ‘Universal dominated reduced −0.65 Results are highly sensitive about and, particular, funding comes care or local government budgets. By analysing who loses gains expenditure decisions, distributional decision makers ways improve reduce inequality.

参考文章(20)
Miqdad Asaria, Susan Griffin, Richard Cookson, Sophie Whyte, Paul Tappenden, Distributional cost-effectiveness analysis of health care programmes--a methodological case study of the UK Bowel Cancer Screening Programme. Health Economics. ,vol. 24, pp. 742- 754 ,(2015) , 10.1002/HEC.3058
Irwin D. J. Bross, How to Use Ridit Analysis Biometrics. ,vol. 14, pp. 18- 38 ,(1958) , 10.2307/2527727
Vivian Welch, Mark Petticrew, Peter Tugwell, David Moher, Jennifer O'Neill, Elizabeth Waters, Howard White, PRISMA-Equity Bellagio group, None, PRISMA-Equity 2012 Extension: Reporting Guidelines for Systematic Reviews with a Focus on Health Equity PLoS Medicine. ,vol. 9, pp. e1001333- ,(2012) , 10.1371/JOURNAL.PMED.1001333
L. Owen, A. Morgan, A. Fischer, S. Ellis, A. Hoy, M. P. Kelly, The cost-effectiveness of public health interventions Journal of Public Health. ,vol. 34, pp. 37- 45 ,(2012) , 10.1093/PUBMED/FDR075
Theo Lorenc, Mark Petticrew, Vivian Welch, Peter Tugwell, What types of interventions generate inequalities? Evidence from systematic reviews Journal of Epidemiology and Community Health. ,vol. 67, pp. 190- 193 ,(2013) , 10.1136/JECH-2012-201257
Koonal K. Shah, Richard Cookson, Anthony J. Culyer, Peter Littlejohns, NICE's social value judgements about equity in health and health care. Health Economics, Policy and Law. ,vol. 8, pp. 145- 165 ,(2013) , 10.1017/S1744133112000096
Matthew Robson, Miqdad Asaria, Richard Cookson, Aki Tsuchiya, Shehzad Ali, Eliciting the Level of Health Inequality Aversion in England. Health Economics. ,vol. 26, pp. 1328- 1334 ,(2017) , 10.1002/HEC.3430
Chris Kypridemos, Kirk Allen, Graeme L Hickey, Maria Guzman-Castillo, Piotr Bandosz, Iain Buchan, Simon Capewell, Martin O’Flaherty, Cardiovascular screening to reduce the burden from cardiovascular disease: microsimulation study to quantify policy options BMJ. ,vol. 353, pp. 2793- ,(2016) , 10.1136/BMJ.I2793
Gillian D. Sanders, Peter J. Neumann, Anirban Basu, Dan W. Brock, David Feeny, Murray Krahn, Karen M. Kuntz, David O. Meltzer, Douglas K. Owens, Lisa A. Prosser, Joshua A. Salomon, Mark J. Sculpher, Thomas A. Trikalinos, Louise B. Russell, Joanna E. Siegel, Theodore G. Ganiats, Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses JAMA. ,vol. 316, pp. 1093- 1103 ,(2016) , 10.1001/JAMA.2016.12195